Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma…
Lack of Assurance of Sterility
Read the official notice →- Date
- 2022-01-19
- Country
- United States
- Brand
- Exela Pharma Sciences
- Product
- 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Manufactured and Distributed by: Exela Pharma…
- Classification
- Class II
- Units
- Nationwide within the United States
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Exela Pharma Sciences recalls
- 2025-09-17
USExela Pharma Sciences LLC recalls 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only,…
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
- 2025-04-02
- US
- 2023-11-29
- US
- 2022-12-21
- US
Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd…
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
- 2022-11-02
- US
Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only,…
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Other drugs & medical recalls in the United States
- 2022-01-19
- US
Taro Pharmaceuticals U.S.A., Inc. recalls Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel…
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
FDA · DrugTaro Pharmaceuticals U.S.A., Inc.Two distributors in UT and LA who could have further distributed to the retail…Official notice → - US
- US
Teva Pharmaceuticals USA recalls MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for:…
Lack of Assurance of Sterility
FDA · DrugTeva Pharmaceuticals USAMethylprednisolone, TN Norepinephrine BItartrate - MS, OHOfficial notice → - US
- US
RemedyRepack Inc. recalls Metformin 750 mg Extended Release NDC # 70518-2920-00
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
- US